CLBTCellebrite DI Ltd.

Nasdaq cellebrite.com


$ 16.86 $ -0.03 (-0.18 %)    

Thursday, 22-Aug-2024 11:33:17 EDT
QQQ $ 479.76 $ -4.41 (-0.91 %)
DIA $ 407.68 $ -2.76 (-0.67 %)
SPY $ 558.98 $ -3.43 (-0.61 %)
TLT $ 97.74 $ -0.47 (-0.48 %)
GLD $ 228.87 $ -1.40 (-0.61 %)
$ 16.62
$ 16.89
$ 16.84 x 100
$ 16.87 x 106
$ 16.84 - $ 17.03
$ 6.37 - $ 17.00
1,424,501
na
3.25B
$ 0.95
$ 26.88
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 deutsche-bank-maintains-buy-on-cellebrite-di-raises-price-target-to-18

Deutsche Bank analyst Jamie Shelton maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $15 to...

 b-of-a-securities-maintains-buy-on-cellebrite-di-raises-price-target-to-17

B of A Securities analyst Tal Liani maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $13 to...

 jp-morgan-maintains-overweight-on-cellebrite-di-raises-price-target-to-17

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $15 t...

 lake-street-maintains-buy-on-cellebrite-di-raises-price-target-to-17

Lake Street analyst Frank Takkinen maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $13.5 t...

 craig-hallum-maintains-buy-on-cellebrite-di-raises-price-target-to-20

Craig-Hallum analyst Jeff Van Rhee maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $16 to ...

 needham-maintains-buy-on-cellebrite-di-raises-price-target-to-17

Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $14 to $17.

 cellebrite-di-q2-2024-adj-eps-010-beats-005-estimate-sales-95714m-beat-91963m-estimate

Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.05 b...

 jp-morgan-maintains-overweight-on-cellebrite-di-raises-price-target-to-15

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $14 t...

 fbi-reportedly-used-israel-based-security-firms-unreleased-technology-to-crack-trump-shooters-phone

Despite having a license for Cellebrite's software, the FBI's Pittsburgh bureau was unable to bypass the passcode on Cr...

 jp-morgan-maintains-overweight-on-cellebrite-di-raises-price-target-to-14

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $12 t...

 needham-maintains-buy-on-cellebrite-di-raises-price-target-to-14

Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $13.5 to $14.

 why-software-company-cellebrite-shares-are-up-today

Cellebrite DI reported strong Q1 FY24 results with revenue up 26% YoY, ARR at $331.8 million, and EPS beating consensus. Outloo...

 cellebrite-di-q1-2024-adj-eps-008-beats-006-estimate-sales-89582m-beat-87757m-estimate

Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.06 b...

 lake-street-initiates-coverage-on-cellebrite-di-with-buy-rating-announces-price-target-of-13

Lake Street analyst Frank Takkinen initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and announces Price T...

 craig-hallum-maintains-buy-on-cellebrite-di-raises-price-target-to-16

Craig-Hallum analyst Jeff Van Rhee maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $14 to ...

 b-of-a-securities-maintains-buy-on-cellebrite-di-raises-price-target-to-13

B of A Securities analyst Tal Liani maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $12 to...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION